213 related articles for article (PubMed ID: 2597121)
1. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.
Tomlinson S; Taylor PW; Morgan BP; Luzio JP
Biochem J; 1989 Oct; 263(2):505-11. PubMed ID: 2597121
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
Joiner KA; Hammer CH; Brown EJ; Frank MM
J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
4. Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity.
Tomlinson S; Taylor PW; Luzio JP
Biochemistry; 1990 Feb; 29(7):1852-60. PubMed ID: 2184889
[TBL] [Abstract][Full Text] [Related]
5. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
6. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
Martin DE; Chiu FJ; Gigli I; Müller-Eberhard HJ
J Clin Invest; 1987 Jul; 80(1):226-33. PubMed ID: 3597774
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism.
Taylor PW
Exp Clin Immunogenet; 1992; 9(1):48-56. PubMed ID: 1642903
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
10. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.
Dankert JR; Esser AF
Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
12. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
13. Studies of the association of the eighth and ninth components of human complement within the membrane-bound cytolytic complex.
Monahan JB; Stewart JL; Sodetz JM
J Biol Chem; 1983 Apr; 258(8):5056-62. PubMed ID: 6833292
[TBL] [Abstract][Full Text] [Related]
14. Does complement kill E. coli by producing transmural pores?
Born J; Bhakdi S
Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981
[TBL] [Abstract][Full Text] [Related]
15. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.
Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA
Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562
[TBL] [Abstract][Full Text] [Related]
16. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
17. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
Stewart JL; Monahan JB; Brickner A; Sodetz JM
Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
[TBL] [Abstract][Full Text] [Related]
18. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
Zalman LS; Wood LM; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-catalyzed disulfide-linking of C9 in the membrane attack complex of complement.
Yamamoto K; Kawashima T; Migita S
J Biol Chem; 1982 Aug; 257(15):8573-6. PubMed ID: 7096325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]